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(st4529, st4547, st4532, st4545, and st3018, with
accession numbers AF060368, AF052426,
AF077666, AF077668, and AF077669, respec-
tively). The newly found group A st4545
sequence was more similar to various group G
streptococcal  emm sequences than to known
group A emm sequences. One group G isolate had
a previously found group G 5' emm sequence
(stLG6, accession number U25741). The
nongroupable Streptococcus had an emm
sequence previously associated with group L
Streptococcus (Beall and Facklam, unpub. data).
These results demonstrate the usefulness of
emm typing in areas where specific M-typing
antisera are not available.
Identifying 6 (25%) of 24 GAS with new emm
types provides further evidence of new M
serotypes of GAS in Malaysia. The deduced
amino acid sequences of the mature hypervariable
N termini of ST4529, ST4532, ST4547, and
ST3018 ranged from 43% to 82% identity to M
proteins of known sequence (data not shown).
The M nontypability of these isolates suggests
unique serologic specificity. ST4547, ST4532,
and ST3018 had 70% to 82% identity over the
first 55-variable-region amino acids, with their
closest matching known M proteins (M70, M27,
and M22, respectively), but whether antibodies
against any of these proteins would cross-protect
against strains expressing these M proteins is
unknown. Even though the M70 protein is 70%
identical over its first 50 variable N terminal
amino acids to the M33 protein, antibodies
against the M70 and M33 proteins do not cross-
protect, which suggests that no cross-protection
would occur. The new deduced M protein with
the lowest similarity to any known M protein was
ST4529, whose closest match had a 43% identity
over the N-terminal 55 residues of the M5
protein.  st4529 likely encodes a new
serospecifically unique M protein.
These findings potentially affect vaccine
development. Although new emm sequences
were identified in a survey in the United States
(5), the percentage of new strains with new emm
sequences was much lower (6%) than was found
with these Malaysian isolates. emm typing of a
larger number of strains from rheumatic fever
and rheumatic heart diseaseendemic areas is
required to deduce amino acid sequences for
the development of a suitable M protein
based  vaccine.
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Mutant Chemokine Receptor (CCR-5) and
Its Relevance to HIV Infection in Arabs
To the Editor: Approximately 10% of HIV-
infected patients may remain AIDS-free for a
long time; moreover, some persons do not become
infected with HIV despite multiple high-risk
sexual exposures (1,2). Factors responsible for
this relative resistance to infection and disease
include cytotoxic T cells, neutralizing antibodies,
high concentrations of certain chemokines (e.g.,184 Emerging Infectious Diseases Vol. 5, No. 1, JanuaryFebruary 1999
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RANTES, MIP-1), human leukocyte antigen
haplotype, mannose-binding protein, and tumor
necrosis factor alpha, C4, and TAP polymor-
phism (2-4). One of the chemokine receptors,
CCR-5, which along with CD4 acts as co-receptor
for HIV entry into macrophages, provides upon
mutation a genetic restriction to HIV infection in
homozygous persons and control of disease
progression in heterozygous persons (5,6). Thus
a 32bp deletion in the open reading frame of the
region encoding the second extracellular loop of
this receptor causes synthesis of a highly truncated
protein that fails to express on the cell surface,
leading to loss of HIV-1 co-receptor activity.
Studies in healthy Caucasian Europeans and
North Americans show that approximately 1% of
the population are homozygous for this deletion
(D32), whereas 15% to 20% are heterozygous (5-
9); surprisingly, a higher percentage (up to 20%)
of persons at high risk for HIV but HIV-negative
are homozygous for this deletion. However, no
such mutation is seen in Japanese, Native
Americans, Chinese, Africans, and Tamil
Indians, which suggests that in these groups
either resistance to HIV infection is not present
or factors other than mutated CCR-5 are in
operation. African-Americans and Hispanics
show a low rate of mutation, possibly because of
intermarriage with Caucasians (4). The low
frequency of CCR-5 mutation in Arabs with close
contacts with Turks in the Eastern Province of
Saudi Arabia may also be due to intermarriage.
However, certain persons with mutated CCR-5
can become HIV-infected (10); in such cases
other chemokine receptors (e.g., CXCR-4, CCR-
2, and CCR-3) are believed to facilitate infection.
HIV infection in Saudi Arabia (population 18
million) is uncommon; the World Health
Organization has so far (1985 to 1997)
documented 334 cases of AIDS in this region (11).
We, therefore, studied for the first time the
mutation of CCR-5 in Arabs residing in Saudi
Arabia. DNA was isolated from the peripheral
blood mononuclear cells of 105 male blood donors
not infected with HIV and nine HIV-infected
patients (seven male and two female). The latter
were divided into three groups, according to
published criteria (2): four persons whose
infection did not progress over the long term and
who showed only modest decline of CD4 count
after several years of infection, one person whose
infection progressed normally, and four persons
whose infection progressed rapidly and CD4
count fell below 100/µl within 2 years. Primers
flanking 32 nucleotide deletion of CCR-5 were
used to generate wild type (W) and deleted (D32)
fragments of 189 bp and 157 bp, respectively (5).
Amplification was done in a Perkin-Elmer
thermal cycler 9,600, by a 20 µl reaction mixture
that contained 0.25mM of dNTPs, 20 pM of each
primer ('5-CAAAAAGAAGGTCTTCATTACACC-
3,5-CCTGTGCCTCTTCTTCTCATTTCG-3'), and
0.5 units of Taq polymerase in 1x reaction buffer.
All reagents were obtained from Pharmacia
(Sweden). The amplified product was separated
on 2% agarose at 120 V for 45 min and examined
under UV light. Of the uninfected blood donors,
104 (99%) were homozygous for the wild type,
and 1 (0.96) was heterozygous for the mutation.
None of the HIV-infected patients had the
mutation. Thus, the mutation is present, albeit
infrequently, in Arabs. A review of 68 HIV-
infected patients in our files showed that, as in
Caucasians, infection progressed rapidly in 8%,
did not progress over the long term in 6%, and
progressed normally in 86% (2). Therefore, other
hitherto unknown protective factors must be
operative in Arabs.
Iman H. Al-Sheikh, Amjad Rahi,
and Mohammed Al-Khalifa
King Faisal University and Regional Laboratory,
Ministry of Health, Dammam, Saudi Arabia
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